AU Stock MarketDetailed Quotes

CHMO Chimeric Therapeutics Ltd

Watchlist

0.001
0.0000.00%

20min DelayTrading Mar 25 16:00 AET

886.77KMarket Cap0.00P/E (Static)

Chimeric Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

Total revenue

Cost of revenue

Gross profit

Operating expense

71.54%29.49M

9.55%17.19M

15.69M

Selling and administrative expenses

30.50%11.92M

48.14%9.14M

--6.17M

-Selling and marketing expense

----

--148.69K

-General and administrative expense

30.50%11.92M

51.80%9.14M

--6.02M

Research and development costs

160.43%13.47M

36.94%5.17M

--3.78M

Depreciation amortization depletion

1.64%965.35K

12.14%949.76K

--846.96K

-Depreciation and amortization

1.64%965.35K

12.14%949.76K

--846.96K

Other operating expenses

61.95%3.12M

-60.63%1.93M

--4.9M

Operating profit

-71.54%-29.49M

-9.55%-17.19M

-15.69M

Net non-operating interest income (expenses)

-19.00%-746.28K

-19,310.40%-627.15K

-3.23K

Non-operating interest income

112.41%27.57K

390.44%12.98K

--2.65K

Non-operating interest expense

20.89%773.85K

10,792.07%640.13K

--5.88K

Other net income (expenses)

131.77%4.83M

889.33%2.08M

-263.79K

Special income (charges)

-18.55%-2.45K

---2.07K

----

-Gain on sale of property,plant,equipment

-18.55%-2.45K

---2.07K

----

Other non-operating income (expenses)

131.66%4.83M

890.11%2.08M

---263.79K

Income before tax

-61.47%-25.41M

-4.11%-15.73M

-15.11M

Income tax

-43.31%92.82K

163.72K

Earnings from equity interest net of tax

Net income

-60.40%-25.5M

-5.19%-15.9M

-15.11M

Net income continuous operations

-60.40%-25.5M

-5.19%-15.9M

---15.11M

Noncontrolling interests

Net income attributable to the company

-60.40%-25.5M

-5.19%-15.9M

-15.11M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-60.40%-25.5M

-5.19%-15.9M

-15.11M

Diluted earnings per share

Basic earnings per share

Dividend per share

Accounting Standards

US-GAAP

	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021
Total revenue
Cost of revenue
Gross profit
Operating expense	71.54%29.49M	9.55%17.19M	15.69M
Selling and administrative expenses	30.50%11.92M	48.14%9.14M	--6.17M
-Selling and marketing expense	----	----	--148.69K
-General and administrative expense	30.50%11.92M	51.80%9.14M	--6.02M
Research and development costs	160.43%13.47M	36.94%5.17M	--3.78M
Depreciation amortization depletion	1.64%965.35K	12.14%949.76K	--846.96K
-Depreciation and amortization	1.64%965.35K	12.14%949.76K	--846.96K
Other operating expenses	61.95%3.12M	-60.63%1.93M	--4.9M
Operating profit	-71.54%-29.49M	-9.55%-17.19M	-15.69M
Net non-operating interest income (expenses)	-19.00%-746.28K	-19,310.40%-627.15K	-3.23K
Non-operating interest income	112.41%27.57K	390.44%12.98K	--2.65K
Non-operating interest expense	20.89%773.85K	10,792.07%640.13K	--5.88K
Other net income (expenses)	131.77%4.83M	889.33%2.08M	-263.79K
Special income (charges)	-18.55%-2.45K	---2.07K	----
-Gain on sale of property,plant,equipment	-18.55%-2.45K	---2.07K	----
Other non-operating income (expenses)	131.66%4.83M	890.11%2.08M	---263.79K
Income before tax	-61.47%-25.41M	-4.11%-15.73M	-15.11M
Income tax	-43.31%92.82K	163.72K	0
Earnings from equity interest net of tax
Net income	-60.40%-25.5M	-5.19%-15.9M	-15.11M
Net income continuous operations	-60.40%-25.5M	-5.19%-15.9M	---15.11M
Noncontrolling interests
Net income attributable to the company	-60.40%-25.5M	-5.19%-15.9M	-15.11M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	-60.40%-25.5M	-5.19%-15.9M	-15.11M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall